1. Home
  2. SDA vs CTSO Comparison

SDA vs CTSO Comparison

Compare SDA & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SDA

SunCar Technology Group Inc.

N/A

Current Price

$0.24

Market Cap

29.6M

Sector

Finance

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$4.50

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SDA
CTSO
Founded
2007
1997
Country
China
United States
Employees
544
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
23.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
SDA
CTSO
Price
$0.24
$4.50
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
★ 151.0K
57.9K
Earning Date
09-22-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
$21.66
$4.91
Revenue Next Year
$11.14
$13.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.27
$0.30
52 Week High
$2.70
$7.44

Technical Indicators

Market Signals
Indicator
SDA
CTSO
Relative Strength Index (RSI) 30.18 54.32
Support Level N/A $2.88
Resistance Level $0.46 $7.44
Average True Range (ATR) 0.06 0.72
MACD -0.00 0.05
Stochastic Oscillator 19.76 46.36

Price Performance

Historical Comparison
SDA
CTSO

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: